Clinical Trial

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the safety and pharmacokinetic characteristics after administration of DWJ1589 and DWC202315 in healty adult volunteers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-09.
Trial Details
NCT Number NCT06592495
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healthy Volunteers
Enrollment 52 participants
Start Date 2024-10
Primary Completion 2025-01 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-23